- Home
- PRME vs VMO Comparison
PRME vs VMO Comparison
Compare PRME & VMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- VMO
- Stock Information
- Founded
- PRME 2019
- VMO 1992
- Country
- PRME United States
- VMO United States
- Employees
- PRME N/A
- VMO N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- VMO Trusts Except Educational Religious and Charitable
- Sector
- PRME Health Care
- VMO Finance
- Exchange
- PRME Nasdaq
- VMO Nasdaq
- Market Cap
- PRME 693.5M
- VMO 608.3M
- IPO Year
- PRME 2022
- VMO N/A
- Fundamental
- Price
- PRME $5.78
- VMO $9.53
- Analyst Decision
- PRME Buy
- VMO
- Analyst Count
- PRME 6
- VMO 0
- Target Price
- PRME $8.88
- VMO N/A
- AVG Volume (30 Days)
- PRME 3.8M
- VMO 254.7K
- Earning Date
- PRME 11-11-2025
- VMO 01-01-0001
- Dividend Yield
- PRME N/A
- VMO 4.39%
- EPS Growth
- PRME N/A
- VMO N/A
- EPS
- PRME N/A
- VMO N/A
- Revenue
- PRME $4,961,000.00
- VMO N/A
- Revenue This Year
- PRME $179.58
- VMO N/A
- Revenue Next Year
- PRME N/A
- VMO N/A
- P/E Ratio
- PRME N/A
- VMO N/A
- Revenue Growth
- PRME 739.42
- VMO N/A
- 52 Week Low
- PRME $1.11
- VMO $7.86
- 52 Week High
- PRME $6.94
- VMO $9.87
- Technical
- Relative Strength Index (RSI)
- PRME 60.95
- VMO 53.72
- Support Level
- PRME $4.87
- VMO $9.48
- Resistance Level
- PRME $6.94
- VMO $9.56
- Average True Range (ATR)
- PRME 0.49
- VMO 0.06
- MACD
- PRME 0.07
- VMO -0.01
- Stochastic Oscillator
- PRME 47.88
- VMO 23.26
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About VMO Invesco Municipal Opportunity Trust
Invesco Municipal Opportunity Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.